NCT05016869 2022-08-18
Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer
ChineseAMS
Phase 1/2 Unknown
Clinical Trials
14 trialsNCT04390958 2022-03-15
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
ChineseAMS
Phase 2 Unknown
NCT04119622 2022-03-11
Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer
ChineseAMS
Phase 2 Unknown
NCT05089643 2022-01-10
Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT01917279 2020-07-23
CAMELLIA
ChineseAMS
Phase 3 Unknown
NCT04380103 2020-05-08
A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer
ChineseAMS
Phase 1/2 Unknown
NCT03923166 2019-04-22
Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT03381352 2018-01-30
Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer
ChineseAMS
Phase 2 Unknown
NCT02947061 2016-10-31
S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT02403544 2016-01-05
Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma
ChineseAMS
Phase 1 Unknown
NCT01928680 2015-02-23
Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT01871363 2013-06-06
Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer
ChineseAMS
Phase 2 Unknown
NCT01679327 2012-09-06
Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer
ChineseAMS
Phase 2 Unknown
NCT01126138 2011-05-04
Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)
ChineseAMS
Phase 3 Unknown